CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...